Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hank Lockman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Human Antibodies|March 13, 2008
A human antibody against anthrax protective antigen protects rabbits from lethal infection with aerosolized sporesMartha A Wild, Karen Kumor, Mary Jean Nolan, et al.
Clinical and Vaccine Immunology : CVI|July 31, 2015
Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine EfficacyPatricia Fellows, Jessica Price, Shannon Martin, et al.
Microbial Pathogenesis|November 3, 2010
Cynomolgus macaque model for pneumonic plagueRichard Warren, Hank Lockman, Roy Barnewall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2022
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I StudyDeborah M Stephens, Ying Huang, Amy S Ruppert, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Human Antibodies|March 13, 2008
A human antibody against anthrax protective antigen protects rabbits from lethal infection with aerosolized sporesMartha A Wild, Karen Kumor, Mary Jean Nolan, et al.
Clinical and Vaccine Immunology : CVI|July 31, 2015
Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine EfficacyPatricia Fellows, Jessica Price, Shannon Martin, et al.
Microbial Pathogenesis|November 3, 2010
Cynomolgus macaque model for pneumonic plagueRichard Warren, Hank Lockman, Roy Barnewall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2022
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I StudyDeborah M Stephens, Ying Huang, Amy S Ruppert, et al.
Pageof 1